Literature DB >> 31080649

Endoscopic resection for early esophageal carcinoma.

Irma C Noordzij1, Wouter L Curvers1, Erik J Schoon1.   

Abstract

Endoscopic resection for early esophageal cancer is a very precise endoscopic surgical technique and having experience in endoscopic resection is mandatory to perform these kinds of procedures safely. In case of adequate resection and favorable histological outcome, long-term prognosis of the patient is excellent. The basic principle for endoscopic treatment of early adenocarcinoma is based on the fact that the risk of lymph node metastasis gradually increases with the depth of invasion. Inspection and evaluation of all mucosal and submucosal lesions need to be done carefully before endoscopic resection. Endoscopic resection of mucosal (T1m1-3) and superficial submucosal (T1sm1) adenocarcinoma can be curative as well as for superficial mucosal (T1m1-m2) squamous cell carcinoma. In Paris type I lesions in Barrett's esophagus and for early squamous cell carcinoma endoscopic submucosal dissection (ESD) is the preferred option. The risk of severe adverse events associated with endoscopic resection are low. Most adverse events are managed endoscopically and can be treated conservatively. Endoscopic radiofrequency ablation is the most widely used ablation technique for Barrett's epithelium and highly effective to achieve full remission of dysplasia and intestinal metaplasia. The role of radiofrequency ablation in the treatment armamentarium in squamous cell carcinoma of the esophagus has still to be determined.

Entities:  

Keywords:  Esophageal neoplasms; endoscopic mucosal resection (EMR); endoscopic submucosal dissection (ESD); esophageal Barrett carcinoma; esophageal squamous cell carcinoma

Year:  2019        PMID: 31080649      PMCID: PMC6503291          DOI: 10.21037/jtd.2019.03.19

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  6 in total

Review 1.  Gastrointestinal Motility Issues in Cancer Patients.

Authors:  Mehnaz A Shafi
Journal:  Curr Gastroenterol Rep       Date:  2019-12-10

2.  Subtotal stomach in esophageal reconstruction surgery achieves an anastomotic leakage rate of less than 1%.

Authors:  Kazuhiro Yoshida; Yoshihiro Tanaka; Takeharu Imai; Yuta Sato; Yuji Hatanaka; Tomonari Suetsugu; Naoki Okumura; Nobuhisa Matsuhashi; Takao Takahashi; Kazuya Yamaguchi
Journal:  Ann Gastroenterol Surg       Date:  2020-05-10

Review 3.  Endoscopic Management of Esophageal Cancer.

Authors:  Christopher Paiji; Alireza Sedarat
Journal:  Cancers (Basel)       Date:  2022-07-22       Impact factor: 6.575

4.  Isothiocyanates (ITCs) 1-(Isothiocyanatomethyl)-4-phenylbenzene and 1-Isothiocyanato-3,5-bis(trifluoromethyl)benzene-Aldehyde Dehydrogenase (ALDH) Inhibitors, Decreases Cisplatin Tolerance and Migratory Ability of NSCLC.

Authors:  Jolanta Kryczka; Jakub Kryczka; Łukasz Janczewski; Anna Gajda; Andrzej Frączyk; Joanna Boncela; Beata Kolesińska; Ewa Brzeziańska-Lasota
Journal:  Int J Mol Sci       Date:  2022-08-03       Impact factor: 6.208

5.  Long-Term Outcomes and Prognostic Factors of Superficial Esophageal Cancer in Patients Aged ≥ 65 Years.

Authors:  Jin Won Chang; Da Hyun Jung; Cheal Wung Huh; Jun Chul Park; Sung Kwan Shin; Sang Kil Lee; Yong Chan Lee
Journal:  Front Med (Lausanne)       Date:  2022-01-18

6.  Endoscopic Submucosal Dissection Versus Surgery for Superficial Esophageal Squamous Cell Carcinoma: A Propensity Score-Matched Survival Analysis.

Authors:  Hyun Deok Lee; Hyunsoo Chung; Yoonjin Kwak; Jinju Choi; Ayoung Lee; Jue Lie Kim; Soo-Jeong Cho; Sang Gyun Kim
Journal:  Clin Transl Gastroenterol       Date:  2020-07       Impact factor: 4.396

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.